Birin, Axl P.
HRN: 24-97-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/15/2024
11/22/2024
INTRAVENOUS
75 Mg IV
Q24H
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes